Texas Equine Veterinary Association

www.texasequineva.com • 28 The following series will feature mobile applications available for Apple and Android users that offer many benefits for veterinary practitioners. Some of these benefits include veterinary medical references, practice management tools, and enhanced organization. Each installment in this series will briefly highlight one mobile app and its use in the veterinary medical field. Stride: Stride is a mileage and expense tracking mobile app, which allows users to maximize their federal tax deductions. This has key benefits for solo ambulatory practitioners and for practices where veterinarians use their own vehicles. The 2020 IRS standard mileage rate for business use is 57.5 cents per mile driven. This can quickly amount to a large tax deduction, which could otherwise be partially or completely overlooked if not accurately tracking mileage. The app is free, available for Apple and Android users, and is easy to use. Users simply open and start the mobile app when they start driving and the app automatically captures the number of miles driven that day. In addition, the app allows users to easily track expenses, such as continuing education travel related expenses. Other similar mobile applications include Hurdlr, MileIQ, and Everlance. These platforms all have a free base level, which allows for a set number of trips per month, and premium packages that cost about $60 per year. Technology Technology SerieS SerieS ABOUT THE AUTHOR Ginger Reed, VMD MBA, was born in eastern Pennsylvania and graduated from the University of Pennsylvania School of Veterinary Medicine in 2012. She completed an internship and worked as an associate at Rood and Riddle Equine Hospital before relocating to the Austin area with her family in 2014 and starting her ambulatory equine practice, Equipuncture Integrative Veterinary Services. In fall 2019, she obtained her MBA from Texas State University. by Ginger Reed, VMD MBA In the spring of 2019, I wrote an article on equine hepatitis viruses and promised updates as they were available. The main hepatitis virus of concern is Equine Parvovirus (EqPV-H), formerly known as Theiler's disease. Some of the novel take home-points are as follows: • There are two methods of known transmission: biologic and non- biologic transmission. Biologic transmission has been documented after the administration of tetanus antitoxin, plasma, allogenic stem cells, etc. Interestingly enough, non-biologic transmission has occurred in horses in contact with known carriers but the route of transmission is unknown. • There are also several forms of the disease that have been documented from inapparent carriers, to lethargy/ADR, to fulminant hepatitis. • Increased GGT is the most commonly abnormal lab parameter. The USDA recently published a notice regarding the Parvovirus Letter From The Editor- Parvovirus Biologic Update status of biologic products including equine derived antivenom. The deadline for biologic companies to have both parvovirus status labeling on their products and to have all donors tested negative is now extended until April of 2021. If you haven't already done this, I highly suggest that you test your clinic's blood donors. When using serum for ophthalmic or stem cell purposes, use autologous serum. Also, any suspect or confirmed Parvovirus cases should be isolated until we elucidate the method of non-biologic transmission. We will continue to update you as new data is published. Regards, Piper Norton, DVM, DACVIM by Piper Norton, DVM, DACVIM

• Cover